Interventions to enhance testing and linkage to treatment for hepatitis C infection for people who inject drugs
A systematic review and meta-analysis
Dados Bibliográficos
| ID | 14907620 |
|---|---|
| Autores | Evan B Cunningham (0000-0002-8048-3473), Alice Wheeler, Behzad Hajarizadeh (0000-0003-2212-2028), Clare E French (0000-0002-6943-7353), Rachel Roche (0000-0002-5929-3616), April D Marshall (0000-0001-7476-7894), Guillaume Fontaine (0000-0002-7806-814X), Anne Conway (0000-0002-9082-9714), Sahar Bajis (0000-0003-2663-3845), Braulio M Valencia (0000-0001-6741-3908), Justin Presseau (0000-0002-2132-0703), John W Ward (0000-0001-7186-6416), Louisa Degenhardt (0000-0002-8513-2218), Gregory J Dore (0000-0002-4741-2622), Matthew Hickman (0000-0001-9864-459X), Peter Vickerman (0000-0002-8291-5890), J Grebely (0000-0002-1833-2017) |
| Ano | 2023 |
| Volume | 111 |
| Páginas | 103917 |
| Data de publicação | 2023-01-01 |
| Peer Reviewed | Sim |
| Open Access | Sim |
| Tipo | ARTICLE |
| Periódico | International Journal of Drug Policy (JOURNAL) |
| Identificadores do periódico | ISSN: 0955-3959 • E-ISSN: 1873-4758 |
| Editora | Elsevier BV (PUBLISHER) |
| DOI | 10.1016/j.drugpo.2022.103917 |
| Idioma | EN |
| Citações recebidas | 12 |
| Referências citadas | 68 |
How far are we? Assessing progress in hepatitis C response towards the WHO 2030 elimination goals by the civil society monitoring in 25 European countries, period 2020 to 2023
Preexisting morbidity and 2-year treatment retention in opioid agonist treatment. A population-based data-linkage study in the Czech Republic
Using an intersectionality lens to explore barriers and enablers to hepatitis C point-of-care testing
A peer-delivered mobile model to enhance access to hepatitis C point-of-care testing and treatment
Facilitating access to direct-acting antivirals in a community-based point-of-diagnosis model for hepatitis C treatment
Service provider perceptions of incorporating hepatitis C testing technologies into standard practice
Trends in cause-specific mortality among people with hepatitis C virus in New South Wales, Australia
Peer-delivered mail-order self-collection and linkage to treatment for hepatitis C virus infection among users of a harm reduction service in Denmark
Apparently, you can only be treated once”
Patient preferences for simplified hepatitis C testing modalities among people at risk of hepatitis C infection in Australia
Acceptability of hepatitis C testing using point-of-care testing and dried blood spot collection among people at risk of hepatitis C infection
Mapping the risk environment for peers with lived-living experience working in the alcohol and other drugs sector in Queensland
Global, regional, and country‐level estimates of hepatitis C infection among people who have recently injected drugs
The effects of integrated care
Barriers to HIV testing in Europe
“They look at us like junkies”
Global epidemiology of hepatitis B and hepatitis C in people who inject drugs
Epidemiology and natural history of HCV infection
Robins-I
RoB 2
Guidelines for Accurate and Transparent Health Estimates Reporting
Meta-analysis of Observational Studies in Epidemiology A Proposal for Reporting
Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs
The PRISMA 2020 statement
Patient-centred access to health care
Community health workers and early detection of breast cancer in low-income and middle-income countries
Experience of hepatitis C testing among injecting drug users in Sydney, Australia
Exploring levers and barriers to accessing primary care for marginalised groups and identifying their priorities for primary care provision
Evaluation of two community-controlled peer support services for assessment and treatment of hepatitis C virus infection in opioid substitution treatment clinics
Beyond the willing & the waiting’ — The role of peer-based approaches in hepatitis C diagnosis & treatment
Patient and provider perceived barriers and facilitators to direct acting antiviral hepatitis C treatment among priority populations in high income countries
Stigma at every turn
Conceptualising access in the direct-acting antiviral era
Adherence to sofosbuvir and velpatasvir among people with chronic HCV infection and recent injection drug use
Interventions to increase linkage to care and adherence to treatment for hepatitis C among people who inject drugs
Interventions to enhance testing, linkage to care and treatment uptake for hepatitis C virus infection among people who inject drugs
Model-based cost-effectiveness estimates of testing strategies for diagnosing hepatitis C virus infection in people who use injecting drugs in Senegal
The impact of diabetes education and peer support upon weight and glycemic control of elderly persons with noninsulin dependent diabetes mellitus (NIDDM)
Bundling Rapid Human Immunodeficiency Virus and Hepatitis C Virus Testing to Increase Receipt of Test Results
| Obras citantes distintas | 12 |
|---|---|
| Citações por ano | 4 |
| Intervalo de citações | 2023 - 2026 (4) |
| Velocidade de citação | current |
| Altamente citado | Não |
| Tipos de citação | Neutras: 12 |